Andson Biotech Raises $3.6M Seed Round
ATLANTA, April 30, 2024 – Andson Biotech, a biotools company developing streamlined sample prep and data analytics solutions for mass spectrometry workflows, has successfully closed a $3.6 million round in equity financing. This capital will support hiring talent to accelerate the market introduction of its inline mass spec sample prep solution, DynaCHIP. This patented technology seamlessly integrates into existing mass spec workflows, significantly reducing sample prep times. In addition, Andson will deploy funds to develop DynaMARK, a novel analytics tool that supports emerging cell and gene therapy applications.
